User contributions for Carlo Banez

30 July 2015

• 17:2017:20, 30 July 2015 diff hist +4 Template:RNA antivirals No edit summary
• 17:1917:19, 30 July 2015 diff hist +20 Dasabuvir No edit summary
• 17:1817:18, 30 July 2015 diff hist +38 Template:RNA antivirals No edit summary

29 July 2015

• 19:0019:00, 29 July 2015 diff hist +51 m Ombitasvir No edit summary
• 18:5818:58, 29 July 2015 diff hist +313 Ombitasvir No edit summary
• 18:5418:54, 29 July 2015 diff hist +618 Ombitasvir No edit summary
• 18:4718:47, 29 July 2015 diff hist +265 Paritaprevir No edit summary

20 July 2015

• 16:3716:37, 20 July 2015 diff hist −14 Template:Oral hypoglycemics and insulin analogs - Empagliflozin US FDA approved (August 2014)

26 April 2015

• 18:4918:49, 26 April 2015 diff hist −14 Template:Chemotherapeutic agents - Palbociclib US FDA approved (February 2015)

5 July 2014

• 17:2917:29, 5 July 2014 diff hist −53 Dapagliflozin - link to EMA, FDA information
• 17:1917:19, 5 July 2014 diff hist +6 Albiglutide - link to EMA, FDA information

8 August 2013

• 16:1416:14, 8 August 2013 diff hist +42 Fonofos No edit summary

14 April 2013

• 17:3517:35, 14 April 2013 diff hist −49 Lixisenatide - link to EMA information

8 April 2013

• 17:5517:55, 8 April 2013 diff hist 0 Sodium/glucose cotransporter 2 →SGLT2 inhibitors for diabetes

3 March 2013

• 13:2313:23, 3 March 2013 diff hist +11 Ospemifene - link to FDA information

7 February 2013

• 14:0914:09, 7 February 2013 diff hist +31 Apixaban - link to FDA information

12 January 2013

• 17:5917:59, 12 January 2013 diff hist −14 Template:Antimycobacterials - Bedaquiline approved by US FDA
• 17:5717:57, 12 January 2013 diff hist +755 Bedaquiline - link to FDA information, infobox upgraded from Chembox to Drugbox

1 January 2013

• 00:2300:23, 1 January 2013 diff hist +4 Piperacetazine No edit summary

27 December 2012

• 17:4317:43, 27 December 2012 diff hist −14 Template:Lipid modifying agents - Lomitapide approved by US FDA
• 13:0613:06, 27 December 2012 diff hist −23 Lomitapide No edit summary

18 December 2012

• 16:0316:03, 18 December 2012 diff hist +547 Ponatinib - link to FDA information, infobox upgraded from Chembox to Drugbox

2 December 2012

• 14:0714:07, 2 December 2012 diff hist −1 m Template:Chemotherapeutic agents No edit summary
• 14:0314:03, 2 December 2012 diff hist +43 Carfilzomib →References
• 14:0114:01, 2 December 2012 diff hist +18 Template:Chemotherapeutic agents No edit summary
• 13:5813:58, 2 December 2012 diff hist −51 Carfilzomib - link to FDA information, infobox upgraded from Chembox to Drugbox
• 13:4713:47, 2 December 2012 diff hist +593 Cabozantinib - link to FDA information, infobox upgraded from Chembox to Drugbox

16 November 2012

• 16:2016:20, 16 November 2012 diff hist +43 Cabozantinib →External links
• 16:1916:19, 16 November 2012 diff hist +16 m Template:Targeted cancer therapeutic agents No edit summary

15 November 2012

• 09:5509:55, 15 November 2012 diff hist −38 Tofacitinib - link to FDA information

14 November 2012

• 13:0713:07, 14 November 2012 diff hist +6 Fondaparinux No edit summary

12 November 2012

• 16:3416:34, 12 November 2012 diff hist +77 Asenapine - link to FDA, EMA information

9 November 2012

• 13:5013:50, 9 November 2012 diff hist +29 Mirabegron No edit summary
• 13:4813:48, 9 November 2012 diff hist −43 Mirabegron - link to FDA information
• 13:4713:47, 9 November 2012 diff hist +43 Pasireotide - link to EMA information

7 November 2012

• 14:2414:24, 7 November 2012 diff hist −13 Template:Chemotherapeutic agents - Omacetaxine mepesuccinate approved by US FDA

27 September 2012

• 17:4817:48, 27 September 2012 diff hist +363 Regorafenib - link to FDA information, infobox upgraded from Chembox to Drugbox

22 September 2012

• 16:0616:06, 22 September 2012 diff hist +140 Gilead Sciences →Product portfolio
• 15:4015:40, 22 September 2012 diff hist +21 Abacavir No edit summary

21 September 2012

• 16:2516:25, 21 September 2012 diff hist −40 Elvitegravir/cobicistat/emtricitabine/tenofovir No edit summary
• 16:2016:20, 21 September 2012 diff hist +2 m Lamivudine →History

16 September 2012

• 17:5817:58, 16 September 2012 diff hist +1 m Teriflunomide →Mechanisms of action

14 September 2012

• 10:2410:24, 14 September 2012 diff hist +160 Teriflunomide - link to FDA information

6 September 2012

• 13:5213:52, 6 September 2012 diff hist +10 Bosutinib No edit summary
• 13:5213:52, 6 September 2012 diff hist +550 Bosutinib - noting FDA approval, link to FDA information

1 September 2012

• 14:1314:13, 1 September 2012 diff hist −73 Linaclotide - link to FDA information
• 14:0314:03, 1 September 2012 diff hist +5 Abiraterone acetate →See also
• 14:0214:02, 1 September 2012 diff hist −97 Enzalutamide - link to FDA information

17 August 2012

• 16:1516:15, 17 August 2012 diff hist +30 Ticagrelor No edit summary
• 16:1316:13, 17 August 2012 diff hist +30 Dabigatran No edit summary